Biopharmaceutical Contract Manufacturing Market Biopharmaceutical Contract Manufacturing Learn how outsourcing trends in biopharma m ...
Fourth quarter earnings per share (diluted) of $1.37, an increase of 34.3% compared to fourth quarter 2023 Fourth quarter net income of $130.1 million Fourth quarter ...
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...